Background Biphenotypic acute leukemia is a rare disorder that is difficult to diagnose. It
displays features of both myeloid and lymphoid lineage. There is still a lack of studies in …

We retrospectively analyzed 449 patients with AML under the WHO classification of AML 2008
and probed implications of this classification in diagnosis and treatment of acute myeloid …

The aim of this study was to explore the synergistic effect of arsenic trioxide and bortezomib
on apoptosis of Raji cell line. The cells were treated with arsenic trioxide, bortezomib, low-…

This study was purposed to investigate the differences of cyto biological characteristics and
protein expression levels between bortezomib-resistant T-lymphoblastic lymphoma/leukemia …

Objective To evaluate the efficacy of rituximab combined with CHOP-like regimen with or
without IFN in patients newly diagnosed diffuse large B-cell Non-Hodgkin’s lymphoma (DLBCL)…

Discussion This patient had been diagnosed with MM for 5 years. After repeated chemotherapy,
the MM was well controlled. Especially after one cycle of bortezomib based treatment, …

Objective: To study the molecular mechanism of different tumorigenicity in nude mice of
human leukemia cell lines K562-n and K562. Methods: To analyze the genes differently …

Objective: To explore the effects of dexamethasone (DXM) and vincristine (VCR) on cytosine
arabinoside (Ara-C) induced apoptosis and activation of nuclear factor-K-gene binding (NF-…

Objective To evaluate the therapeutic efficiency and adverse effect of the fludarabine-containing
regimens in the treatment of low grade non-Hodgkin's lymphoma. Methods Thirty-two …

The proteasome is primarily responsible for intracellular protein degradation. The abnormality
of its activity is sign of tumorigenesis. It was confirmed that proteasome inhibitors have …